Parallax Volatility Advisers, L.P. Axogen, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $7,763 - $12,745	-228 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $23,389 - $33,967	-647 Reduced 73.94%	228 $11,000
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $81,130 - $133,831	-3,325 Reduced 79.17%	875 $32,000
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $77,700 - $120,120	4,200	4,200 $119,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.